Andere Sprachen AnaptysBio, Inc.

Aktien

A2AJ8C

US0327241065

ANAB

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 03.05.2024			% 5 Tage	% 1. Jan.
26,58 ^USD	+0,91 %		+26,57 %	+24,09 %

16.04.	ANAPTYSBIO, INC. : erhält Kaufen-Rating von Leerink Partners	ZM
11.04.	ANAPTYSBIO, INC. : Bewertung von Wells Fargo Securities zum Kaufen erhalten	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AnaptysBio, Inc.(NasdaqGS:ANAB) added to S&P Biotechnology Select Industry Index	18.03.
North American Morning Briefing : Stock Futures -2-	13.03.
AnaptysBio Shares Jump on Upgrade by Wedbush	12.03.
AnaptysBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11.03.
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	11.03.
AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	11.03.
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting	29.02.
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting	29.02.
AnaptysBio Shares Climb as Piper Sandler Starts Coverage With Overweight Rating	16.02.
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference	31.01.
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference	31.01.
AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from S&P Biotechnology Select Industry Index	18.12.
GSK : l'UE approuve Jemperli dans le cancer de l'endomètre	11.12.
AnaptysBio Secures Exclusive License for Centessa's BDCA2 Modulator Antibody Portfolio	27.11.
Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals	27.11.
Anaptys Named a BioSpace 2024 Best Places to Work Winner	07.11.
Anaptys Named a BioSpace 2024 Best Places to Work Winner	07.11.
Acne Vulgaris Pipeline\| Clinical Trials, Key Companies - Novan, Bausch Health AOBiome, Ascletis Pharmaceuticals, AnaptysBio, Botanix Pharmaceuticals	07.11.
AnaptysBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02.11.
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update	02.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AnaptysBio, Inc.

Aktien

A2AJ8C

US0327241065

ANAB

Andere Sprachen

Filter